Notice convening 39th Annual General Meeting ("AGM") of Fredun Pharmaceuticals Limited
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fredun Pharmaceuticals has sent out the notice for its 39th Annual General Meeting scheduled for Tuesday, June 30, 2026 at 9:00 AM, to be held via Video Conferencing. Shareholders will consider adopting the FY2025-26 audited financials and declaring a 7% dividend on equity shares. The meeting also includes a proposal to issue bonus shares in a 2:1 ratio (2 free shares for every 1 held) by capitalising free reserves, and to increase authorised share capital from ₹10 crore to ₹50 crore. Additionally, shareholders will vote on raising the company's borrowing and investment limits up to ₹600 crore, ratifying the cost auditor's fee of ₹1.25 lakh, and re-appointing Dr. Mrs. D. N. Medhora as a director. Book closure is from June 24 to June 30, 2026, with the e-voting cut-off date set at June 23, 2026.
If approved, shareholders stand to receive a 7% dividend and triple their shareholding via the 2:1 bonus issue, though the share price typically adjusts downward on the ex-bonus date. The higher borrowing limit (₹600 crore) signals potential expansion or acquisitions ahead, which could mean more dilution risk later but also growth opportunities.